Eliciting Informed Goals of Care in Elderly Patients (ASKMEGOC)

November 18, 2025 updated by: Giulio DiDiodato, Royal Victoria Hospital, Canada

Assessment of Shared Decision-making Tool for Eliciting Informed Goals of Care in the Hospitalized Elderly (ASKMEGOC): A Randomized Clinical Trial

Patient-centered medical care considers a patient's values and goals for their health and well-being. Healthcare providers use this information to formulate a medical care plan that is aligned with these expectations. This shared-decision making process should occur with every medical decision, but it is especially important whenever decisions about end-of-life care are being considered. Eliciting patient preferences about resuscitation and life-support treatments in the event of life-threatening illnesses are considered to be a standard of excellent and appropriate medical care. Unfortunately, these discussions don't happen consistently and even when they do occur, are rarely ideal. The consequences can be devastating, often resulting in the delivery of unwanted medical care that can be associated with significant physical and mental suffering among patients and their families. In response to this problem, the investigators developed a novel tool to help guide these difficult conversations between healthcare providers and patients. The investigators previously tested this tool in a small group of hospitalized patients who found it acceptable and helpful. In this larger study, the investigators will compare how effective this tool is compared to usual care in ensuring hospitalized patients have their treatment preferences identified, documented and result in end-of-life care that is consistent with their preferences.

Study Overview

Status

Recruiting

Detailed Description

Objectives:

  1. To determine the impact of facilitated Goals of Care Discussions (GOCDs) on the number of ICU, ventilator, and dialysis days during the index hospitalization (or until death) (composite).
  2. To determine the impact of facilitated GOCDs on the number of ICU, ventilator, and dialysis days after the index hospitalization until 12 months post-admission from the index hospitalization (or until death) (composite).
  3. To determine the impact of f-GOCDs on the final treatment preferences for life sustaining treatments (LSTs) documented in CODE STATUS.
  4. To determine the impact of facilitated GOCDs on other outcomes including decisional conflict and quality of communication, patient satisfaction with the encounter, and place of death.
  5. To determine the difference in direct patient hospital costs
  6. To determine the barriers and facilitators to the implementation of GOCDs.

Design:

A prospective, single-centre, stratified, parallel group, allocation concealed, analyst-masked, randomized, pragmatic, mixed-method, comparative effectiveness trial in hospitalized elderly patients 80 years and older.

Participants:

This study will include all elderly patients admitted to the Royal Victoria Regional Health Centre in Barrie, Ontario, Canada, with an acute medical or surgical diagnosis who fulfill all the inclusion criteria and for whom none of the exclusion criteria exist.

Study Type

Interventional

Enrollment (Estimated)

1200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ontario
      • Barrie, Ontario, Canada, L4M6M2
        • Recruiting
        • Royal Victoria Regional Health Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hospitalized patients ≥ 80 years old with an acute medical or surgical condition admitted to any hospital ward
  • Previously or currently documented CODE STATUS preferences include any life sustaining therapies
  • Duration of admission ≥ 24 hours
  • English speaking, or translator present
  • Competent patient or substitute decision maker

Exclusion Criteria:

  • Treating physician, patient, or substitute decision maker declines
  • Documented resuscitation preferences for comfort or supportive care
  • New diagnosis of life-limiting illness on this hospital admission, for example, new diagnosis of metastatic cancer
  • Clinically unstable, admitted to an intensive care unit, or currently receiving acute life support treatment (mechanical ventilation, acute dialysis, or inotropic/vasopressor support)
  • Readmission after index hospitalization
  • Pre-existing need for chronic mechanical ventilation (invasive mechanical ventilation via tracheostomy > 90 days) or maintenance dialysis (peritoneal or hemodialysis > 90 days)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GOCD Tool
Intensive care unit-facilitated goals-of-care discussion using web-based shared-decision making software tool
Web-based tool with 4 components; pre-admission health status; current illness prognosis for hospital survival; in-hospital cardiorespiratory arrest prognosis; values and goals of care
Active Comparator: usual care
Usual discussions conducted by attending physician with patient
Attending physicians responsible for GOCD during hospitalization using their usual approaches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICU-related health care utilization
Time Frame: From the time of index hospital admission until hospital discharge or death, up to 12 months after the time of index hospital admission
total number of ventilator, ICU, and dialysis days
From the time of index hospital admission until hospital discharge or death, up to 12 months after the time of index hospital admission
ICU-related health care utilization
Time Frame: 12 months after admission from index hospital admission
total number of hospital, ventilator, ICU, and dialysis days
12 months after admission from index hospital admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CODE STATUS resuscitation preferences
Time Frame: At the time of index hospital discharge or death during the index hospitalization, up to 12 months after the time of index hospital admission
Distribution of resuscitation preferences documented in CODE STATUS
At the time of index hospital discharge or death during the index hospitalization, up to 12 months after the time of index hospital admission
Change in CODE STATUS preferences
Time Frame: At the time of index hospital discharge or death during the index hospitalization, up to 12 months after the time of index hospital admission
Proportion of patients who change documented CODE STATUS preferences
At the time of index hospital discharge or death during the index hospitalization, up to 12 months after the time of index hospital admission
Resuscitation level designation
Time Frame: At the time of index hospital discharge or death, up to 12 months after the time of index hospital admission
proportion of patients with completed resuscitation preferences identified
At the time of index hospital discharge or death, up to 12 months after the time of index hospital admission
Distribution of ICU-related days of health care utilization
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
compare empirical distributions of total days of health care utilization
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Time required to complete GOCD-facilitated discussion
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Total time required to complete intervention
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Quality of communication
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
assessment of patient perceptions of quality of goals of care discussion
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
patient satisfaction with GOCD discussion
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
patient satisfaction with goals of care discussions
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Evaluation of GOCD tool
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
patient's perceptions of quality of web-based tool
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Patient-provider agreement on resuscitation preferences
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
decision concordance between patients and providers
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Death
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
date and time and place of death during study period
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Direct hospital costs
Time Frame: From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months
Difference in direct hospital costs
From index hospital admission until hospital discharge or death in hospital, assessed up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giulio DiDiodato, MD PhD, Royal Victoria Regional Health Centre
  • Principal Investigator: Chris Martin, MD, Royal Victoria Regional Health Centre
  • Principal Investigator: Doug Austgarden, MD, Royal Victoria Regional Health Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

July 27, 2023

First Submitted That Met QC Criteria

August 14, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Only upon request, de-identified data may be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End of Life

Clinical Trials on GOCD Tool

Subscribe